Statistical analysis indicated significantly enhanced concentrations of MCP-1 (p = 0.001; Figure 2A) and MCP-4 (p = 0.001; Figure 2B) in serum of ALS patients compared to healthy controls. This evidence concerns the gene CCL13 and amyotrophic lateral sclerosis.